Helicobacter pylori is a pathogenic microorganism that mainly resides in the human stomach
and is the major cause of chronic gastritis, peptic ulcer and gastric cancer. Up to now, the …

Helicobacter pylori is the most prevalent chronic bacterial infection, with approximately half
of the world's population estimated to be colonized. The World Health Organization (WHO) …

Objective We performed a meta-analysis to determine whether the addition of probiotics to
the bismuth quadruple therapy (BQT) for Helicobacter pylori would improve the incidence of …

Background and aims: The purpose of this umbrella meta-analysis was to quantitatively
summarize meta-analyses of randomized controlled trial (RCT) studies regarding the effects …

Helicobacter pylori (H. pylori) is a gram-negative bacterium exhibiting high pathogenicity.
Traditional antibiotic treatments are considered ineffective as the H. pylori resistance has …

Diagnostic and therapeutic recommendations on Helicobacter pylori infection.
Recommendations of the Working Group of the Polis Page 1 Creative Commons licenses …

Background and study aims The aim of this study was to evaluate the efficacy of probiotic as
an adjuvant in quadruple therapy for H. pylori eradication compared with placebo. Patients …

Helicobacter pylori infection is the most common infectious disease worldwide. It is
associated with duodenal and gastric ulcer disease and the risk of gastric neoplasia. The …

Background. Probiotic therapy (Pb) has been used in several gastrointestinal disorders.
Some studies evaluated Pb in rheumatic diseases. However, there is no systematic review …

Background. Helicobacter pylori infection has long been suspected to increase the risk of
thyroid diseases but evidence from literature is conflicting. In a cohort of patients from …